The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine

Background/Aims We evaluated the role of next-generation sequencing (NGS)-based disease monitoring for elderly patients diagnosed with acute myeloid leukemia (AML) who received decitabine therapy. Methods A total of 123 patients aged > 65 years with AML who received decitabine were eligible. We anal...

Cijeli opis

Bibliografski detalji

Glavni autori:	Mihee Kim, TaeHyung Kim, Seo-Yeon Ahn, Jun Hyung Lee, Ju Heon Park, Myung-Geun Shin, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Seung Hyun Choi, Mi Yeon Kim, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim
Format:	Artigo
Jezik:	Inglês
Izdano:	The Korean Association of Internal Medicine 2023-07-01
Serija:	The Korean Journal of Internal Medicine
Teme:	acute myeloid leukemia elderly patients decitabine allele frequency residual neoplasm
Online pristup:	http://kjim.org/upload/kjim-2022-396.pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!